Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
about
Consequences of repeated blood-brain barrier disruption in football playersExtracranial sources of S100B do not affect serum levelsPathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated areaPathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative productsBlood biomarkers for brain injury: What are we measuring?Blood-brain barrier, bulk flow, and interstitial clearance in epilepsyEfficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epilepticsSerum S100B: a potential biomarker for suicidality in adolescents?GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitusProApolipoprotein A1: a serum marker of brain metastases in lung cancer patientsBrain magnetic resonance spectroscopy in episodic hepatic encephalopathy.Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphologicalImproving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkersValidation of serum markers for blood-brain barrier disruption in traumatic brain injury.Peripheral markers of brain damage and blood-brain barrier dysfunctionIs peripheral immunity regulated by blood-brain barrier permeability changes?Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin ResistanceHigh S100B levels in cerebrospinal fluid and peripheral blood of patients with acute basal ganglial hemorrhage are associated with poor outcomeThe S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Blood-brain barrier integrity may be threatened by exercise in a warm environment.Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic reviewSignificance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hitsEarly postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational studyTrajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injuryS100B blood levels and childhood trauma in adolescent inpatientsS100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDSModulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implicationA lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.Neuropsychological testing and biomarkers in the management of brain metastasesThe potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer.Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.Serum S100B represents a new biomarker for mood disorders.S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.
P2860
Q21133671-171E26A2-3750-43CA-948B-A6BC2063CA9FQ22241536-73DADF31-C2B6-401E-8597-4A2457C515C1Q24627871-7B2CECF3-A7BF-4979-A911-528D1A4EE46CQ26777643-74D8E9BF-888B-4070-9CF9-6B68DFC58DACQ28067275-FA38AA0D-7F1A-4DAB-8924-D487C6D75BD2Q28086846-A9EFA774-70A1-41E0-91C7-F04FBAA101FBQ28477533-659E9C35-12E7-4B18-9CE3-78A78C80F66FQ28751578-74C6EEB3-ADE1-4ED2-B798-30677F3835E3Q30430711-564BC58E-D73C-4188-804E-3CF622EE320CQ30485388-070CB3F5-CC9E-4DB7-8494-DE2A6C588546Q30578055-4509BE22-329F-4729-8E6B-AB4042F8290EQ33370648-AF551FF3-5D10-42F9-9050-E346C79E299AQ33504619-278FCA5E-5CD7-4666-A81C-F8A4B201FDA9Q33595790-54CCD04F-2298-4451-8D73-A92F0BB4590AQ33657728-1B06C1A9-CE02-4656-8D5A-167862B63A1AQ33789473-60F680CA-CBD4-49A8-9EB9-F02D2CB42D9BQ33838466-7B856940-177A-4297-BB6F-6C6840E9DF3DQ33863821-475C360D-4B14-4920-8540-A1B101E22BBEQ33984573-392F24D3-B1BE-4833-82FE-2C5DAB6A84F1Q34031981-39CF26BD-0D5D-477E-A006-17197C17DBB0Q34238722-3FE84273-40C7-4CCA-853E-B8717E866436Q34384307-3DCAB2C2-37A8-4A22-9FB6-E858703DABD3Q35067781-E1DD2D61-C71A-4367-85C8-6D75A8F18643Q35109940-91C046C3-6278-489D-AA8B-0CB5A1899ED2Q35136554-2A26BF4A-A94D-4C18-9DAC-6B3A7371F86AQ35164692-8B2BECB4-F8EA-4B94-AF67-86DBCE7DEB3AQ35544698-7EDFD04E-CCE9-40C3-A647-D13C93B9A171Q35547437-FEB13F92-596A-4988-A8B9-B43A8A0AE842Q35551126-E203E965-F130-45C5-9CFF-288E6A637677Q35603172-448A55D8-1426-4969-91B1-1944A3DAAA80Q35778571-5D920470-B8FA-44AD-8DA0-97B7DF060492Q35785224-134EDB15-7B1C-44CD-AA80-667902719D18Q35984262-DA0D4C17-41E5-4B03-A711-BEF18336AB70Q36763899-BEF61E52-48EE-4336-BFDC-35D7D1CB1EBEQ36915247-0021F019-79E0-4650-83B6-0F232DE03CCEQ37154481-39B9040B-2D08-4C93-A8FC-893E2F7633E5Q37227291-5F99365F-C8BC-4335-9401-F6750C9FA48BQ37250446-D840099A-361A-4463-B6C0-19AA5F43CCA3Q37290664-B8AE9367-5360-4C87-9A31-196BDDE76313Q37318243-6A9C7AED-74F1-4C98-A7F1-2BEEC3AA9071
P2860
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@ast
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@en
type
label
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@ast
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@en
prefLabel
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@ast
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@en
P2093
P2860
P50
P356
P1433
P1476
Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
@en
P2093
Andrew A Kanner
Barbara Aumayr
Glen H J Stevens
Marc R Mayberg
Michael A Vogelbaum
Michael T Koltz
Thomas Masaryk
Vincent Fazio
Vitaly Siomin
P2860
P304
P356
10.1002/CNCR.11409
P407
P577
2003-06-01T00:00:00Z